Results of heart transplantation in recipients with active infection.
Although active infection in the recipient is generally considered to be an absolute contraindication for heart transplantation, seven of our first 104 transplant patients (6.7%) had active severe infection within the week before transplantation. Because of unstable clinical condition of these recipients, heart transplantation was performed when an adequate donor was offered, in spite of infection. Patients were managed with cyclosporine as the only immunosuppressive therapy during the first week after transplantation. Mortality rate and incidence of acute rejection were not different for these seven patients than for the remaining 97 patients.
Anguita
M
M
Heart Transplantation Unit, Reina Sofía Hospital, University of Córdoba, Spain.
Arizón
J M
JM
Vallés
F
F
Torres
F
F
López-Rubio
F
F
Concha
M
M
D000293:Adolescent; D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D016470:Bacteremia / Q000382:microbiology; D001424:Bacterial Infections / Q000188:drug therapy / Q000382:microbiology / Q000503:physiopathology*; D002311:Cardiomyopathy, Dilated / Q000601:surgery; D016572:Cyclosporine / Q000627:therapeutic use; D005260:Female; D006084:Graft Rejection / Q000209:etiology; D006085:Graft Survival; D016027:Heart Transplantation / Q000009:adverse effects / Q000379:methods; D006801:Humans; D006976:Hypertension, Pulmonary / Q000209:etiology; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D015996:Survival Rate
D016572:Cyclosporine; D001379:Azathioprine; D008775:Methylprednisolone